We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Artificial Cells, Nanomedicine, and Biotechnology

Interview with interim Editor-in-Chief Jigisha Patel

Jigisha Patel, Interim Editor-in-Chief

Jigisha Patel joins Artificial Cells, Nanomedicine and Biotechnology in duel-roles as interim Editor-In-Chief and Independent Research Integrity Consultant.

The below interview offers authors interested in submitting to the journal, a straightforward guide on how to prepare your submission, plus insightful updates on new policies and challenges currently facing scientific publishing.

Authors should carefully read the journal’s Aims and Scope and Instructions for Authors pages to ensure their manuscript adheres to the journal’s scope and editorial policies. This journal offers format-free submissions, meaning authors may submit their paper in any scholarly format or layout, but must contain all relevant sections required for peer review. If you require assistance to polish your manuscript prior to submission, Taylor & Francis provides a range of editing services to assist you.

SUBMIT NOW

Q: Tell us a little about your academic and professional background and expertise.                                                                                                       

A: My background is in medicine. I earned my first degree in Medicine and studied for my PhD from Queen Mary University in London, UK. I worked as a hospital doctor for several years, including a year at the National Institutes of Health in Bethesda, Maryland, USA, before moving into publishing. I have worked in publishing for over 13 years, first as a professional medical editor for a series of medical journals and then as a specialist in research integrity.

It is my expertise in managing complicated publication ethics issues that I bring to the journal.

Q: You have recently been elected to the Council of the Committee on Publication Ethics (COPE).

What are the biggest challenges currently facing the publishing community in ensuring research integrity, and what policies and processes does the journal have in place to protect against integrity issues?

A: The pressure on researchers to show their success by the number of articles they publish is driving a range of behaviors including questionable practices, such as cutting corners when doing and writing up research; misconduct, such as plagiarism; and outright attempts to manipulate the publication process, such as falsifying research, high-jacking peer review and selling authorship of manuscripts. These are the most immediate challenges facing many journals and publishers.

To meet these challenges, Artificial Cells, Nanomedicine and Biotechnology has policies requiring authors to provide certain types of raw data for verification by the journal. It also has strict criteria for allowing changes in authorship of a manuscript after submission. In addition to existing standard pre-review checks, enhanced processes have recently been put in place to verify author identity and check for image manipulation.

Importantly, the journal is committed to supporting all researchers by becoming more transparent about its expectations of authors in terms of editorial standards and by providing feedback to authors when those standards are not met.

"The journal is committed to supporting all researchers by becoming more transparent about its expectations of authors in terms of editorial standards and by providing feedback to authors when those standards are not met."

Q: What advice and support would you offer prospective authors putting together a submission to the journal?

A: I can't stress enough the importance of checking the journal's policies and instructions for authors and ensuring the submission complies with the instructions. This saves time and will help to make the submission run more smoothly through the peer review process.

It's also a good idea to write a proper cover letter to the editor explaining why your research should be considered by the journal, for example, by highlighting which parts of the aims and scope your submission addresses.

"Write a proper cover letter to the editor...highlighting which parts of the aims and scope you think your submission addresses."

Q: What does the data policy, share upon reasonable request mean and what data is required on submission?

A: Data sharing is important because it allows other researchers to repeat the authors' analyses and validate their findings or to reuse the data for further analyses, thereby reducing waste. In accordance with the Taylor & Francis share upon reasonable request data sharing policy authors are required to provide a data availability statement, detailing where the data associated with the paper can be accessed.

If the article includes immunostaining or microscopy images, it is mandatory to attach the full frame image with the submission. If the article includes immunoblots or PCR gels the original image should be supplied, along with molecular weight markers. It is the author's responsibility to ensure the soundness of the data, and vitally important that this detail is offered as transparently as possible.

"Data sharing is important because it allows other researchers...to reuse the data for further analyses, thereby reducing waste."

A Checklist for Your Submission

Ready to submit your manuscript? Follow the link below, to review a checklist for authors preparing to submit their research to Artificial Cells, Nanomedicine, and Biotechnology.
REVIEW CHECKLIST